**Author details**

Anthony Man1 \* and Florencia Segal<sup>2</sup>

1 Global Health Development Unit, Novartis Pharma AG, Basel, Switzerland

2 Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, MA, USA

\*Address all correspondence to: manyl4123@yahoo.com

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*New Therapeutics for Chagas Disease: Charting a Course to Drug Approval DOI: http://dx.doi.org/10.5772/intechopen.102891*
